MARTORANA, FEDERICA
MARTORANA, FEDERICA
MEDICINA CLINICA E SPERIMENTALE
148P The impact of chemotherapy relative dose intensity on pathological complete response and event-free survival in patients with triple-negative breast cancer treated with neoadjuvant chemotherapy
file da validare2024-01-01 Buonaiuto, R.; Martorana, F.; Marino, P.; Caltavituro, A.; Neola, G.; Trasacco, P.; Longobardi, A.; Mangiacotti, F. P.; Molinaro, V.; Caso, C.; La Spina, F.; Di Rienzo, R.; Grieco, A.; Simeone, A.; Pietroluongo, E.; Forestieri, V.; Giuliano, M.; Arpino, G.; De Angelis, C.; Vigneri, P.
A new kid on the block: Sacituzumab govitecan for the treatment of breast cancer and other solid tumors
2021-01-01 Pavone, G.; Motta, L.; Martorana, F.; Motta, G.; Vigneri, P.
A novel system for semiautomatic sample processing in chronic myeloid leukaemia: Increasing throughput without impacting on molecular monitoring at time of sars-cov-2 pandemic
2021-01-01 Stella, S.; Vitale, S. R.; Massimino, M.; Puma, A.; Tomarchio, C.; Pennisi, M. S.; Tirro, E.; Romano, C.; Martorana, F.; Stagno, F.; Di Raimondo, F.; Manzella, L.
A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy
2024-01-01 Gebbia, V.; Martorana, F.; Scandurra, G.; Valerio, M. R.; Cufari, S.; Vigneri, P.; Sano, M. V.; Scollo, P.
A review and metanalysis of metronomic oral single-agent cyclophosphamide for treating advanced ovarian carcinoma in the era of precision medicine
2024-01-01 Martorana, F.; Scandurra, G.; Valerio, M. R.; Cufari, S.; Vigneri, P.; Sano, M. V.; Scibilia, G.; Scollo, P.; Gebbia, V.
A systematic review of phase II trials exploring anti-PD-1/PD-L1 combinations in patients with solid tumors
2021-01-01 Martorana, F.; Colombo, I.; Treglia, G.; Gillessen, S.; Stathis, A.
Abemaciclib pharmacology and interactions in the treatment of HR+/HER2− breast cancer: a critical review
2024-01-01 Martorana, F.; Sano, M. V.; Valerio, M. R.; Fogli, S.; Vigneri, P.; Danesi, R.; Gebbia, V.
Abemaciclib-associated Diarrhea: An Exploratory Analysis of Real-life Data
2023-01-01 Gebbia, Vittorio; Martorana, Federica; Sanò, Maria Vita; Valerio, Maria Rosaria; Giotta, Francesco; Spada, Massimiliano; Piazza, Dario; Caruso, Michele; Vigneri, Paolo
Activation of the IGF axis in thyroid cancer: Implications for tumorigenesis and treatment
2019-01-01 Manzella, L.; Massimino, M.; Stella, S.; Tirro, E.; Pennisi, M. S.; Martorana, F.; Motta, G.; Vitale, S. R.; Puma, A.; Romano, C.; Di Gregorio, S.; Russo, M.; Malandrino, P.; Vigneri, P.
Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery
2021-01-01 Di Franco, S.; Bianca, P.; Sardina, D. S.; Turdo, A.; Gaggianesi, M.; Veschi, V.; Nicotra, A.; Mangiapane, L. R.; Lo Iacono, M.; Pillitteri, I.; van Hooff, S.; Martorana, F.; Motta, G.; Gulotta, E.; Lentini, V. L.; Martorana, E.; Fiori, M. E.; Vieni, S.; Bongiorno, M. R.; Giannone, G.; Giuffrida, D.; Memeo, L.; Colarossi, L.; Mare, M.; Vigneri, P.; Todaro, M.; De Maria, R.; Medema, J. P.; Stassi, G.
AKT Inhibitors: New Weapons in the Fight Against Breast Cancer?
2021-01-01 Martorana, F.; Motta, G.; Pavone, G.; Motta, L.; Stella, S.; Vitale, S. R.; Manzella, L.; Vigneri, P.
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype
file da validare2018-01-01 Gerratana, L; Basile, D; Buono, G; De Placido, S; Giuliano, M; Minichillo, S; Coinu, A; Martorana, F; De Santo, I; Del Mastro, L; De Laurentiis, M; Puglisi, F; Arpino, G
Antibody-Drug Conjugates to Promote Immune Surveillance: Lessons Learned from Breast Cancer
file da validare2024-01-01 Nucera, S.; Conti, C.; Martorana, F.; Wilson, B.; Genta, S.
Biomarkers and prognostic factors for malignant pleural mesothelioma
2015-01-01 Vigneri, Paolo; Martorana, F; Manzella, Livia; Stella, S.
Can we learn from failures? A systematic review of phase III trials in platinum-resistant ovarian cancer
2025-01-01 Martorana, Federica; Pavone, Giuliana; Sessa, Cristiana; Treglia, Giorgio; Lheureux, Stephanie; Colombo, Ilaria
Correlation between weight and Recurrence Score in a cohort of HR+ve/ HER2-ve early breast cancer patients: a retrospective analysis
file da validare2024-01-01 Di Grazia, G.; Signorelli, R.; Martorana, F.; Vigneri, P.
Delayed use of eribulin in a heavily pretreated liposarcoma patient, previously misdiagnosed as leiomyosarcoma
2019-01-01 Martorana, F.; Vigneri, P.; Manzella, L.; Tirrò, E.; Soto Parra, H.
Drivers of choice and outcomes of breast-conserving surgery versus mastectomy in breast cancer patients with complete response following neoadjuvant therapy: a retrospective analysis from the EUSOMA database
file da validare2024-01-01 Martorana, F.; Catanuto, G.; Gentile, D.; Tomatis, M.; Ponti, A.; Marotti, L.; Aristei, C.; Cardoso, M. J.; Cheung, K. L.; Curigliano, G.; de Vries, J.; Santini, D.; Sardanelli, F.; Peter, V. D.; Rubio, I. T.
Early Gastrointestinal Progression to Immunotherapy in Lung Cancer: A Report of Two Cases
2021-01-01 Martorana, Federica; Lanzafame, Katia; Pavone, Giuliana; Motta, Lucia; Motta, Gianmarco; Inzerilli, Nicola; Carciotto, Rosaria; Vecchio, Giada Maria; Zanghì, Antonino; Soto Parra, H.; Magro, Gaetano; Vigneri, Paolo
Efficacy of A Fluoropyrimidine plus Mitomycin C in Pretreated Patients with Metastatic Colorectal Cancer Eligible for Regorafenib: A Retrospective Study
2017-01-01 Martorana, F; Vigneri, P; Cordio, Ss; Martines, C; Novello, G; Aiello, Mm; Bordonaro, R; Soto Parra, H.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 148P The impact of chemotherapy relative dose intensity on pathological complete response and event-free survival in patients with triple-negative breast cancer treated with neoadjuvant chemotherapy | 1-gen-2024 | Buonaiuto, R.; Martorana, F.; Marino, P.; Caltavituro, A.; Neola, G.; Trasacco, P.; Longobardi, A.; Mangiacotti, F. P.; Molinaro, V.; Caso, C.; La Spina, F.; Di Rienzo, R.; Grieco, A.; Simeone, A.; Pietroluongo, E.; Forestieri, V.; Giuliano, M.; Arpino, G.; De Angelis, C.; Vigneri, P. | file da validare |
| A new kid on the block: Sacituzumab govitecan for the treatment of breast cancer and other solid tumors | 1-gen-2021 | Pavone, G.; Motta, L.; Martorana, F.; Motta, G.; Vigneri, P. | |
| A novel system for semiautomatic sample processing in chronic myeloid leukaemia: Increasing throughput without impacting on molecular monitoring at time of sars-cov-2 pandemic | 1-gen-2021 | Stella, S.; Vitale, S. R.; Massimino, M.; Puma, A.; Tomarchio, C.; Pennisi, M. S.; Tirro, E.; Romano, C.; Martorana, F.; Stagno, F.; Di Raimondo, F.; Manzella, L. | |
| A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy | 1-gen-2024 | Gebbia, V.; Martorana, F.; Scandurra, G.; Valerio, M. R.; Cufari, S.; Vigneri, P.; Sano, M. V.; Scollo, P. | |
| A review and metanalysis of metronomic oral single-agent cyclophosphamide for treating advanced ovarian carcinoma in the era of precision medicine | 1-gen-2024 | Martorana, F.; Scandurra, G.; Valerio, M. R.; Cufari, S.; Vigneri, P.; Sano, M. V.; Scibilia, G.; Scollo, P.; Gebbia, V. | |
| A systematic review of phase II trials exploring anti-PD-1/PD-L1 combinations in patients with solid tumors | 1-gen-2021 | Martorana, F.; Colombo, I.; Treglia, G.; Gillessen, S.; Stathis, A. | |
| Abemaciclib pharmacology and interactions in the treatment of HR+/HER2− breast cancer: a critical review | 1-gen-2024 | Martorana, F.; Sano, M. V.; Valerio, M. R.; Fogli, S.; Vigneri, P.; Danesi, R.; Gebbia, V. | |
| Abemaciclib-associated Diarrhea: An Exploratory Analysis of Real-life Data | 1-gen-2023 | Gebbia, Vittorio; Martorana, Federica; Sanò, Maria Vita; Valerio, Maria Rosaria; Giotta, Francesco; Spada, Massimiliano; Piazza, Dario; Caruso, Michele; Vigneri, Paolo | |
| Activation of the IGF axis in thyroid cancer: Implications for tumorigenesis and treatment | 1-gen-2019 | Manzella, L.; Massimino, M.; Stella, S.; Tirro, E.; Pennisi, M. S.; Martorana, F.; Motta, G.; Vitale, S. R.; Puma, A.; Romano, C.; Di Gregorio, S.; Russo, M.; Malandrino, P.; Vigneri, P. | |
| Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery | 1-gen-2021 | Di Franco, S.; Bianca, P.; Sardina, D. S.; Turdo, A.; Gaggianesi, M.; Veschi, V.; Nicotra, A.; Mangiapane, L. R.; Lo Iacono, M.; Pillitteri, I.; van Hooff, S.; Martorana, F.; Motta, G.; Gulotta, E.; Lentini, V. L.; Martorana, E.; Fiori, M. E.; Vieni, S.; Bongiorno, M. R.; Giannone, G.; Giuffrida, D.; Memeo, L.; Colarossi, L.; Mare, M.; Vigneri, P.; Todaro, M.; De Maria, R.; Medema, J. P.; Stassi, G. | |
| AKT Inhibitors: New Weapons in the Fight Against Breast Cancer? | 1-gen-2021 | Martorana, F.; Motta, G.; Pavone, G.; Motta, L.; Stella, S.; Vitale, S. R.; Manzella, L.; Vigneri, P. | |
| Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype | 1-gen-2018 | Gerratana, L; Basile, D; Buono, G; De Placido, S; Giuliano, M; Minichillo, S; Coinu, A; Martorana, F; De Santo, I; Del Mastro, L; De Laurentiis, M; Puglisi, F; Arpino, G | file da validare |
| Antibody-Drug Conjugates to Promote Immune Surveillance: Lessons Learned from Breast Cancer | 1-gen-2024 | Nucera, S.; Conti, C.; Martorana, F.; Wilson, B.; Genta, S. | file da validare |
| Biomarkers and prognostic factors for malignant pleural mesothelioma | 1-gen-2015 | Vigneri, Paolo; Martorana, F; Manzella, Livia; Stella, S. | |
| Can we learn from failures? A systematic review of phase III trials in platinum-resistant ovarian cancer | 1-gen-2025 | Martorana, Federica; Pavone, Giuliana; Sessa, Cristiana; Treglia, Giorgio; Lheureux, Stephanie; Colombo, Ilaria | |
| Correlation between weight and Recurrence Score in a cohort of HR+ve/ HER2-ve early breast cancer patients: a retrospective analysis | 1-gen-2024 | Di Grazia, G.; Signorelli, R.; Martorana, F.; Vigneri, P. | file da validare |
| Delayed use of eribulin in a heavily pretreated liposarcoma patient, previously misdiagnosed as leiomyosarcoma | 1-gen-2019 | Martorana, F.; Vigneri, P.; Manzella, L.; Tirrò, E.; Soto Parra, H. | |
| Drivers of choice and outcomes of breast-conserving surgery versus mastectomy in breast cancer patients with complete response following neoadjuvant therapy: a retrospective analysis from the EUSOMA database | 1-gen-2024 | Martorana, F.; Catanuto, G.; Gentile, D.; Tomatis, M.; Ponti, A.; Marotti, L.; Aristei, C.; Cardoso, M. J.; Cheung, K. L.; Curigliano, G.; de Vries, J.; Santini, D.; Sardanelli, F.; Peter, V. D.; Rubio, I. T. | file da validare |
| Early Gastrointestinal Progression to Immunotherapy in Lung Cancer: A Report of Two Cases | 1-gen-2021 | Martorana, Federica; Lanzafame, Katia; Pavone, Giuliana; Motta, Lucia; Motta, Gianmarco; Inzerilli, Nicola; Carciotto, Rosaria; Vecchio, Giada Maria; Zanghì, Antonino; Soto Parra, H.; Magro, Gaetano; Vigneri, Paolo | |
| Efficacy of A Fluoropyrimidine plus Mitomycin C in Pretreated Patients with Metastatic Colorectal Cancer Eligible for Regorafenib: A Retrospective Study | 1-gen-2017 | Martorana, F; Vigneri, P; Cordio, Ss; Martines, C; Novello, G; Aiello, Mm; Bordonaro, R; Soto Parra, H. |